Listed Norwegian company producing unique Biosensors for the healthcare market
The PSA Biosensor has the potential to improve pre-operative clinical staging of prostate cancer
Mission Statement
InvivoSense mission is to manufacture sensors for high-value medical diagnosis and monitoring applications by combining biophysics with fibre optic technology to provide unique, cost effective solutions.
Products
The Biosensors developed by InvivoSense consist of a platform technology that has the potential to detect a wide variety of protein disease markers from in-vivo and ex-vivo tissue fluid, including cancer.
Measurements are taken in real time and are available to the medical expert in minutes. The Biosensors are easy to use, highly accurate and minimally invasive.
*PSA Biosensor
The PSA Biosensor is the first probe to be developed to accurately measure PSA concentrations in tissue fluid to help optimise staging in prostate cancer.
TMS Biosensor
The first product to become commercially available from InvivoSense is the TMS multi-temp device. It uses the platform technology of biophysics and fibre-optics to detect extreme temperature changes.
The TMS Biosensor was CE marked in 2003
*Invivosense AS 2007 Invivosense PSA Biosensor is currently undergoing trials and has yet to be CE marked. *Patent number GB2385915